| Cat.No. | Product Name | Information | Product Use Citations | Product Validations |
|---|---|---|---|---|
| S2623 | Omecamtiv mecarbil (CK-1827452) | Omecamtiv mecarbil (CK-1827452) is a specific cardiac myosin activator and a clinical drug for left ventricular systolic heart failure, currently in Phase 2. |
|
|
| E6493New | MT-125 | MT-125 is a first-in-class, brain-penetrant small-molecule inhibitor of NMIIA with a Ki of 2.7 μM and NMIIB with an EC50 of 1.7 μM. It also exhibits significant preclinical activity in glioblastoma (GBM) models. | ||
| E6959New | BHB-1893 | BHB-1893 (HRS-1893) is a selective, reversible cardiac myosin ATPase inhibitor. It reduces actin-myosin crossbridge formation and myocardial hypercontractility, and is being developed for hypertrophic cardiomyopathy (HCM), including obstructive HCM. |